GP Pharm is a private Spanish biopharmaceutical firm located in Barcelona area founded in 2000. It is specialized in products for injection mostly within the fields of Oncology and Urology using technological platforms based on Microspheres and Liposomes. The company is working in the complete development of these drugs starting from R&D, pre-clinical and clinical studies and registration until the launch to the market. GP Pharm develops drug delivery formulations for its own and for third parties.

The company´s business model is based on four different areas, i.e. R&D, Contract Manufacturing and Contract Development (CDMO), Licensing In & Out and Commercialization. This is affordable by a continuous investment in research and innovative technologies and a wide experienced team of employees most of which are highly trained and possess a bachelor, master or PhD. In addition, GP Pharm’s state of art manufacturing facilities have been widely approved by different Regulatory Agencies –including EU, US or Japan– allowing the firm to be position in a worldwide setting.

For the commercialization of its products, our firm built up its own commercial structure in Spain and collaborations with well-established international pharmaceutical companies, in order to promote and distribute its portfolio products with licensing and supply agreements. In addition, our enterprise is always open to discuss co-development of its clinical projects in advanced stages.

GP Pharm exploits its broad experience in pharmaceutical product development as well as its modern manufacturing facilities to offer Contract Manufacturing and Contract Development services to third parties.